News Roundup: August 21 to August 25
Your weekly roundup of the latest news from Drug Topics®.
FDA Delays Drug Supply Chain Security Act Deadline Until November 2024
The FDA has issued a 1-year delay on the final enhanced drug distribution security requirements under the Drug Supply Chain Security Act (DSCSA) that were set to take effect in November.
How AI Can Improve Controlled Substance Security
Each year, drug diversion is estimated to cost the US health care system an estimated $70 billion. Outside of these costs, drug diversion poses a significant risk to patient safety and patient’s communities.
In A Post-Dobbs World, Pharmacists Still Face Uncertainty
Legal challenges have made dispensing abortion medications more difficult than ever.
Study Highlights Importance of Preventive Cancer Screenings on Health, Economy
Preventative cancer screenings have added millions of years to the lives of Americans and have saved the United States economy trillions of dollars, according to recent research published in the journal BMC Health Services Research.
FDA Approves Pfizer RSV Vaccine for Use During Pregnancy to Protect Infants
The FDA has approved Pfizer’s bivalent respiratory syncytial virus (RSV) vaccine (Abrysvo) for use during pregnancy to prevent lower respiratory tract disease (LRTD) and severe LRTD caused by RSV in infants from birth through 6 months.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
